Pfizer unit Zoetis plans to sell notes in four maturities Wednesday

By Andrea Heisinger

New York, Jan. 16 - Zoetis Inc. is in Wednesday's market with a private offering of senior notes (Baa2/BBB-/) in four tranches, a market source said.

The notes are being sold via Rule 144A and Regulation S in tranches with maturities of three, five, 10 and 30 years.

Bank of America Merrill Lynch, Barclays and J.P. Morgan Securities LLC are the bookrunners.

Zoetis is an animal health subsidiary of Pfizer Inc., based in New York City.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.